USD 12.38
(2.31%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 2.32 Billion USD | 19.12% |
2022 | 1.95 Billion USD | 12.04% |
2021 | 1.74 Billion USD | -4.45% |
2020 | 1.82 Billion USD | -35.94% |
2019 | 2.84 Billion USD | 27.29% |
2018 | 2.23 Billion USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 2.34 Billion USD | 0.04% |
2024 Q1 | 2.34 Billion USD | 0.82% |
2024 Q3 | 2.35 Billion USD | 0.45% |
2023 Q4 | 2.32 Billion USD | 4.69% |
2023 Q2 | 2.22 Billion USD | -0.02% |
2023 Q1 | 2.22 Billion USD | 13.76% |
2023 Q3 | 2.22 Billion USD | 0.04% |
2023 FY | 2.32 Billion USD | 19.12% |
2022 Q3 | 1.83 Billion USD | -0.22% |
2022 FY | 1.95 Billion USD | 12.04% |
2022 Q4 | 1.95 Billion USD | 6.58% |
2022 Q2 | 1.83 Billion USD | 0.61% |
2022 Q1 | 1.82 Billion USD | 4.72% |
2021 Q3 | 1.82 Billion USD | -4.86% |
2021 Q4 | 1.74 Billion USD | -4.56% |
2021 FY | 1.74 Billion USD | -4.45% |
2021 Q1 | 1.83 Billion USD | 0.7% |
2021 Q2 | 1.92 Billion USD | 4.49% |
2020 Q2 | 2.89 Billion USD | 0.0% |
2020 FY | 1.82 Billion USD | -35.94% |
2020 Q3 | 2.99 Billion USD | 3.39% |
2020 Q4 | 1.82 Billion USD | -38.99% |
2020 Q1 | - USD | -100.0% |
2019 Q1 | - USD | 0.0% |
2019 FY | 2.84 Billion USD | 27.29% |
2019 Q4 | 2.84 Billion USD | 0.0% |
2018 FY | 2.23 Billion USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Aclaris Therapeutics, Inc. | 426 Thousand USD | -546157.277% |
Applied DNA Sciences, Inc. | 1.23 Million USD | -187905.429% |
Aspira Women's Health Inc. | 2.26 Million USD | -102594.44% |
Biodesix, Inc. | 60.69 Million USD | -3734.269% |
BioNexus Gene Lab Corp. | 133.39 Thousand USD | -1744385.176% |
bioAffinity Technologies, Inc. | 1.57 Million USD | -147309.002% |
bioAffinity Technologies, Inc. | 1.57 Million USD | -147309.002% |
Bionano Genomics, Inc. | 87.94 Million USD | -2545.975% |
CareDx, Inc | 34.22 Million USD | -6700.082% |
Check-Cap Ltd. | - USD | -Infinity% |
Castle Biosciences, Inc. | 15.31 Million USD | -15099.582% |
DarioHealth Corp. | 29.54 Million USD | -7777.377% |
Exact Sciences Corporation | 2.55 Billion USD | 8.912% |
Fulgent Genetics, Inc. | 14.9 Million USD | -15510.492% |
Guardant Health, Inc. | 1.35 Billion USD | -71.895% |
ICON Public Limited Company | 3.93 Billion USD | 40.913% |
IDEXX Laboratories, Inc. | 947.88 Million USD | -145.501% |
Illumina, Inc. | 2.26 Billion USD | -2.876% |
Intelligent Bio Solutions Inc. | 871.44 Thousand USD | -266935.711% |
iSpecimen Inc. | 196.24 Thousand USD | -1185697.273% |
Standard BioTools Inc. | 98.21 Million USD | -2269.47% |
MDxHealth SA | 41.26 Million USD | -5539.297% |
23andMe Holding Co. | 76.51 Million USD | -2941.307% |
Medpace Holdings, Inc. | 142.12 Million USD | -1537.365% |
Myriad Genetics, Inc. | 145 Million USD | -1504.866% |
Mainz Biomed B.V. | 7.42 Million USD | -31258.644% |
ENDRA Life Sciences Inc. | 394.4 Thousand USD | -589919.853% |
NeoGenomics, Inc. | 611.67 Million USD | -280.437% |
Neogen Corporation | 906.23 Million USD | -156.782% |
Inotiv, Inc. | 417.64 Million USD | -457.191% |
Natera, Inc. | 441.99 Million USD | -426.492% |
OPKO Health, Inc. | 326.56 Million USD | -612.588% |
Psychemedics Corporation | 2.29 Million USD | -101164.404% |
Prenetics Global Limited | 2.36 Million USD | -98113.378% |
Prenetics Global Limited | 2.36 Million USD | -98113.378% |
Precipio, Inc. | 1.11 Million USD | -208417.563% |
Personalis, Inc. | 48.96 Million USD | -4652.78% |
RadNet, Inc. | 1.49 Billion USD | -56.061% |
Sera Prognostics, Inc. | 1.85 Million USD | -125145.21% |
Neuronetics, Inc. | 62.47 Million USD | -3624.839% |
Star Equity Holdings, Inc. | 3.6 Million USD | -64379.246% |
Star Equity Holdings, Inc. | 3.6 Million USD | -64379.246% |
Trinity Biotech plc | 67.42 Million USD | -3351.223% |
Twist Bioscience Corporation | 94.06 Million USD | -2373.776% |
Exagen Inc. | 23.72 Million USD | -9710.109% |